Serial Echocardiographic Assessment of Patients (Pts) with Relapsed Multiple Myeloma (RMM) Receiving Carfilzomib and Dexamethasone (Kd) Vs Bortezomib and Dexamethasone (Vd): A Substudy of the Phase 3 Endeavor Trial (NCT01568866)
暂无分享，去创建一个
S. Russell | H. Goldschmidt | M. Dimopoulos | G. Gaidano | R. Hájek | A. Oriol | P. Moreau | W. Chng | H. Ludwig | D. Lenihan | A. Lyon | T. Facon | L. Rosiñol | A. Palumbo | D. Joshua | R. Niesvizky | L. Pour | H. Gillenwater | S. Feng | A. Suvorov | V. Goranova-Marinova | N. Mohamed | S. Russell